Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-17
SponsorUniversitas Sebelas Maret

About this trial

The goal of this study is to learn whether a digital tool can help improve HIV knowledge, self-awareness, and testing among adolescents in Yogyakarta, Indonesia. The tool includes online HIV education, a self-assessment for HIV risk, and access to trained peer educators for support. The study will also explore how comfortable and willing adolescents are to use this kind of digital health service.

The main questions the study aims to answer are:

* Can this digital tool help adolescents better understand HIV and their personal risk? * Will more adolescents be willing to get tested for HIV after using the tool? * What factors affect whether adolescents accept and use digital HIV services?

Researchers will compare two groups of high school students:

* One group will use the digital tool for 6 weeks * The other group will receive standard HIV education (not through the tool)

Participants will:

* Answer surveys before and after the 6-week period * Learn about HIV through videos and interactive content * Use the tool to assess their personal HIV risk * Receive support from trained peer educators (online)

The researchers hope this study will lead to new ways of using technology to improve HIV prevention and testing for young people.

Eligibility criteria

Qualifiers

Adolescents aged 15-17 years

Reside or attend school in the Yogyakarta area

Currently enrolled in one of the participating high schools

Able to read and understand Bahasa Indonesia

Disqualifiers

Adolescents outside the 15-17 age range

Unable to access digital devices or internet independently

Previously diagnosed with HIV (as this study targets prevention and self-screening among untested adolescents)

Unwilling or unable to provide informed assent or whose parents/guardians do not provide consent

Trial design

Treatments tested in this trial

  • Digital HIV Education and Self-Screening (EKSTRIM Model)

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators